Safety of Anal Curcumin (NCT06626230)
An Incremental Dose Escalation Trial of Safety and Tolerability of Curcumin
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to see if curcumin can reverse anal high-grade squamous intraepithelial lesions (aHSIL) (high-grade anal precancerous cells or high-grade abnormal cells) in people living with HIV to avoid current treatments such as ablation (destroying abnormal cells with heat or surgical excision (cutting out the abnormal cells)), which have potential short- and long-term side effects.
Who can join: Review the eligibility criteria below.
Location: Grady Memorial Hospital — Atlanta, Georgia
Age range: 30 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Grady Memorial Hospital — Atlanta, Georgia
- Grady Hospital - Ponce De Leon Clinic — Atlanta, Georgia
📞 Contact the Study Coordinator
Phone: (404) 251-8931
Email: lflowe2@emory.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Anal High Grade Squamous Intraepithelial Lesion
Explore by condition: All Anal High Grade Squamous Intraepithelial Lesion clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.